Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome

Leuk Res. 2013 Nov;37(11):1538-44. doi: 10.1016/j.leukres.2013.07.022. Epub 2013 Oct 3.

Abstract

Telomere dysfunction might generate genomic instability leading to the progression of myelodysplastic syndromes (MDS) into acute myeloid leukemia (AML). We investigated telomere length (TL), telomerase activity (TA) and hTERT, c-myc, mad1, and p53 expression in the bone marrow of patients with MDS (n=109), AML (n=47) and in controls (n=24). TL was lower in MDS patients than in controls (p<0.001) and higher in L-MDS (low, intermediate-1 IPSS, p<0.01) respect H-MDS (high, intermediate-2 IPSS, p<0.01) patients. Mad-1 expression was higher in MDS patients than in controls (p<0.01), c-myc expression was highest in AML and in H-MDS patients. Our results show that the telomere dynamics might be useful for stratifying patients according to a risk scoring system.

Keywords: Acute myeloid leukemia; Myelodysplastic syndromes; Telomerase activity; Telomere length; Transcription factors; hTERT.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / genetics*
  • Blotting, Western
  • Case-Control Studies
  • Cell Cycle
  • Cell Cycle Proteins / genetics*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Myelodysplastic Syndromes / classification
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / pathology
  • Nuclear Proteins / genetics*
  • Prognosis
  • Proto-Oncogene Proteins c-myc / genetics*
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Telomerase / genetics
  • Telomere Homeostasis / genetics*

Substances

  • Biomarkers, Tumor
  • Cell Cycle Proteins
  • MAD1L1 protein, human
  • MYC protein, human
  • Nuclear Proteins
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • TERT protein, human
  • Telomerase